FDA approves Emrosi for rosacea in adults
The U.S. Food and Drug Administration has approved Journey Medical's Emrosi (minocycline hydrochloride) for the treatment of ...
WebMD12 天
New Rosacea Treatment Option Approved by the FDA
The FDA has approved an antibiotic called minocycline for the treatment of rosacea in adults. The drug, which is taken orally ...
pharmaphorum15 天
Journey slips on FDA approval of rosacea therapy
Journey Medical has claimed FDA approval for its Emrosi therapy for rosacea, which it thinks could become a "standard of care ...
US FDA approves Journey Medical's drug for long-term skin condition
The U.S. Food and Drug Administration has approved Journey Medical's drug for the treatment of a long-term skin condition ...
GlobalData on MSN14 天
FDA approves Journey Medical’s rosacea treatment Emrosi
Journey Medical's new rosacea treatment will rival industry giant Galderma's Oracea in the treatment of rosacea.
Medpage Today on MSN15 天
FDA Approves New Option for Rosacea
The FDA approved minocycline hydrochloride extended-release capsules (Emrosi) for treating inflammatory lesions of rosacea in ...
healthday7 天
FDA Approves Emrosi for Rosacea in Adults
12, 2024 (HealthDay News) -- The U.S. Food and Drug Administration has approved Emrosi (minocycline hydrochloride ... "Our seasoned dermatology-focused sales force is now preparing for a successful ...
Yahoo Finance15 天
FDA approves Journey Medical’s rosacea treatment Emrosi
The US’ Food and Drug Administration (FDA) has approved Journey Medical’s Emrosi, the brand name for its 40mg minocycline hydrochloride extended-release capsules, to be used in the treatment ...
MedPage Today16 天
FDA Approves New Option for Rosacea
Opens in a new tab or window The FDA approved minocycline hydrochloride extended-release capsules (Emrosi) for treating inflammatory lesions of rosacea ... risks for drug-resistant bacteria ...